| Name | Title | Contact Details |
|---|
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,400 people across 40 countries.
VIDA is the established leader in quantitative pulmonary imaging analysis offering a unique lung imaging evaluation as a service to aid in the early detection, diagnosis, and treatment evaluation of pulmonary diseases.
StimGuard is a privately held medical device company engaged in the development, manufacture, and pre-commercialization of wirelessly powered, microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive, and highly cost-effective urological solution that is easily incorporated into their daily lives. StimGuard`s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic impact of urology care management.
STRATA Skin Sciences is a medical technology company in dermatology dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTRAC® and now Pharos® excimer lasers and VTRAC® lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. The Company`s proprietary XTRAC and recently acquired Pharos excimer lasers deliver a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 31 million patients in the United States alone. STRATA`s unique business model leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company`s partner dermatology clinics.
The Brijjit™ technology is created and produced by BrijjitCo, a limited liability company based in Atlanta, GA.. Our founder and CEO, Felmont (Monte) F. Eaves, III, MD, FACS, is a highly credentialed plastic surgeon who saw a gap and was determined to bridge it. No, we`re not a huge company. Yet. But we are singularly focused on improving the surgical landscape with breakthrough technologies that will support surgeons everywhere in their goal to deliver the most spectacular outcomes. We strongly believe that Brijjit™ is just such an innovation, and we don`t plan to stop there!